| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets and Chemical Biology |
Departments of 1 Surgery, Winship Cancer Institute and 2 Pathology, Emory University School of Medicine, Atlanta, Georgia and 3 The First People's Hospital of Guang Zhou, Guang Zhou, P.R. China
Requests for reprints: Lily Yang, Department of Surgery and Winship Cancer Institute, Emory University School of Medicine, 1365 C Clifton Road Northeast, Atlanta, GA 30322. Phone: 404-778-4269; Fax: 404-778-5530; E-mail: Lyang02{at}emory.edu.
Development of novel approaches for quantitative analysis of gene expression in intact tumor cells should provide new means for cancer detection and for studying the response of cancer cells to biological and therapeutic reagents. We developed procedures for detecting the levels of expression of multiple genes in fixed as well as viable cells using molecular beacon imaging technology. We found that simultaneous delivery of molecular beacons targeting survivin and cyclin D1 mRNAs produced strong fluorescence in breast cancer but not in normal breast cells. Importantly, fluorescence intensity correlated well with the level of gene expression in the cells detected by real-time reverse transcriptionPCR or Western blot analysis. We further show that molecular beacons can detect changes of survivin gene expression in viable cancer cells following epidermal growth factor stimulation, docetaxel treatment, and overexpression of p53 gene. Thus, molecular beacon imaging is a simple and specific method for detecting gene expression in cancer cells. It has great potential for cancer detection and drug development.
Key Words: Breast cancer detection cyclin D1 fluorescence imaging molecular beacon imaging survivin real-time gene expression
This article has been cited by other articles:
![]() |
A. K. Chen, M. A. Behlke, and A. Tsourkas Sub-cellular trafficking and functionality of 2'-O-methyl and 2'-O-methyl-phosphorothioate molecular beacons Nucleic Acids Res., October 9, 2009; (2009) gkp837v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Chen, M. A. Behlke, and A. Tsourkas Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA Nucleic Acids Res., July 1, 2008; 36(12): e69 - e69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Chen, M. A. Behlke, and A. Tsourkas Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells Nucleic Acids Res., August 15, 2007; (2007) gkm593v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Peng, P. Karna, R. M. O'Regan, X. Liu, R. Naithani, R. M. Moriarty, W. C. Wood, H.-Y. Lee, and L. Yang Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells Mol. Pharmacol., January 1, 2007; 71(1): 101 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Peng, P. Karna, Z. Cao, B.-H. Jiang, M. Zhou, and L. Yang Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1{alpha} Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression J. Biol. Chem., September 8, 2006; 281(36): 25903 - 25914. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Marti, S. Jockusch, Z. Li, J. Ju, and N. J. Turro Molecular beacons with intrinsically fluorescent nucleotides. Nucleic Acids Res., January 1, 2006; 34(6): e50 - e50. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |